AI can elevate independents’ inventory management
Das Pattathil, chief executive officer of OnePint.ai
Latest
Some alternatives to TV ads for pharmaceuticals
By Bradley Keefer, chief revenue officer at Keen Decision Systems
Technology can enhance shopping and customize care
By Deborah Weinswig, founder and chief executive officer of Coresight Research
T-Mobile’s 5G technology gives retailers an edge
For the past three years, T-Mobile has made it a point to help retailers seize that opportunity by building solutions around its advanced 5G technology.
CDR/MMR breakfast at NACDS Annual looks at the latest developments in GLP-1 category
The session addressed the latest GLP-1 developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors.
Digital out-of-home ads are a smart bet for pharma
By David Weinfeld, cofounder and chief executive officer of Screenverse
AI: Invaluable tool or unintended hindrance to care?
By Grace Mahas and Jonathon Brown, director of content and chief growth officer, respectively, at Trend Hunter
NACDS Annual Meeting comes at pivotal moment
Exclusive Q&A with NACDS president and CEO Steve Anderson on pressing issues.
Whitman has been the heart and soul of NACDS
David Pinto writes that his longtime friend Jim Whitman can never be replaced once he retires from NACDS. "It’s not just what he did, how often he did it, or how effectively he did it. Rather, it has been the unfailing presence of the man himself."
Travel pain-free with Biofreeze Dry Stick
Travel-enthusiasts are turning to Biofreeze, a TSA-friendly, lightweight solution for managing pain on the go.
The new world of economic uncertainty
President Trump’s fluctuating tariff policies have complicated the decision-making process for executives.
Tylenol launches PRECISE Nighttime Pain Relieving Cream
TYLENOL PRECISE Nighttime Pain Relieving Cream is a fast-acting dual sensation cream that cools on contact and gradually warms up to relieve minor aches and pains.
Bruce Kneeland gears up for 12th Rx road trip
According to Kneeland, this trip, like all the previous ones will allow him to visit the carefully selected pharmacies and interview the owners or senior managers.
Novo Nordisk protects U.S. patients with legal wins against compounders
This includes ruling that permanently prohibits compounding pharmacy from selling illegitimate, knockoff Wegovy or Ozempic.
Astute Analytica: Worldwide nutraceuticals market to reach $668 billion by 2033
The demand for health-oriented products like protein bars and meal replacements underscores a shift toward proactive health management.
New investment model can spark industry innovation
By Tom Furphy, chief executive officer and managing director of Consumer Equity Partners